Short answer
Inhibrx Biosciences, Inc. (INBX) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Earnings release covers full year ended December 31, 2025.
Inhibrx Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings release covers full year ended December 31, 2025
- Financial details not included here; refer to Exhibit 99.1 for key metrics
- Important update on company performance for investor assessment and outlook
- Signals timely disclosure of annual results in line with reporting requirements
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inhibrx Biosciences, Inc. 8-K filings
Get the next INBX 8-K as it lands
Follow INBX for push alerts, or ask the research agent what this filing means.